PIGL
protein-codingphosphatidylinositol glycan anchor biosynthesis class L, the group of MicroRNA protein coding host genes|Phosphatidylinositol glycan anchor biosynthesis
Gene summary
This gene encodes an enzyme that catalyzes the second step of glycosylphosphatidylinositol (GPI) biosynthesis, which is the de-N-acetylation of N-acetylglucosaminylphosphatidylinositol (GlcNAc-PI). Study of a similar rat enzyme suggests that this protein localizes to the endoplasmic reticulum. [provided by RefSeq, Jul 2008]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~134.6 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0010221
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0010221
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0010221
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0010221
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0010221
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0016596
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0010221
Submitter: Genomics England PanelApp
Inheritance Pattern: AR
Disease ID:MONDO:0000508
Submitter: ClinGen
*PIGL* is involved in the biosynthesis of glycosylphosphatidylinositol (GPI), which is required to anchor proteins to the cell membrane. Variants in *PIGL* have been reported in patients with autosomal recessive syndromic intellectual disability, including CHIME syndrome (colobomas, heart defects, ichthyosiform dermatosis, intellectual disability, and ear abnormalities) and Mabry syndrome (hyperphosphatasia intellectual disability syndrome). *PIGL* was first reported in relation to CHIME syndrome in 2012 (Ng et al., PMID: 22444671). Five unrelated probands with CHIME syndrome had compound heterozygous variants in *PIGL*; they all shared the same p.Leu167Pro missense variant and had different null variants in the second allele . Variants in this gene have been reported in at least 12 probands in 8 publications (PMIDs: 22444671, 25706356, 28327575, 28371479, 29444765, 29473937, 30023290, 35258128), including 11 missense (p.Leu167Pro recurrent 8 times), 3 frameshift, 3 nonsense, 2 splice-site, and 3 partial or whole gene deletions . Affected individuals had CHIME syndrome, Mabry syndrome, overlapping features of both syndromes, or intellectual disability with dysmorphic features and seizures. Of note, all individuals with CHIME syndrome reported thus far carried the recurrent p.Leu167Pro variant. This gene-disease relationship is also supported by protein interaction with MEIS2 (PMID: 26186194), biochemical function (PMID: 10085243) and functional alteration in patient cells (PMID: 22444671). In summary, there is definitive evidence supporting the relationship between *PIGL* and autosomal recessive syndromic intellectual disability. This classification was approved by the ClinGen Intellectual Disability and Autism Gene Curation Expert Panel on December 7, 2022 (SOP Version 9).
Clinical Genomic Database (CGD)
Manifestation: Cardiovascular; Craniofacial; Dermatologic; Neurologic; Ophthalmologic
Intervention: Cardiovascular
Rationale: The condition can involve congenital cardiac anomalies, and awareness may allow early management
Comments: The condition can involve multiple congenital anomalies
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to PIGL variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_004278.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 5 | 24 | 29 | |||
| missense | 1 | 4 | 59 | 9 | 73 | |
| nonsense | 2 | 1 | 3 | |||
| start loss | 2 | 2 | ||||
| frameshift | 5 | 2 | 1 | 8 | ||
| splice donor/acceptor (+/-2bp) | 2 | 5 | 1 | 8 | ||
| Total | 10 | 12 | 67 | 34 | 0 | 123 |
Highest pathogenic variant AF is 0.0007388018
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_004269.1 | 7 | MANE Select | |
| Ensembl | ENSP00000225609.5 | 7 | MANE Select | |
| RefSeq | NP_001398001.1 | 6 | Standard | |
| Ensembl | ENSP00000379185.3 | 6 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Glycosylphosphatidylinositol (GPI)-anchor biosynthesis - Homo sapiens (human)
- Synthesis of glycosylphosphatidylinositol (GPI)
- Post-translational modification: synthesis of GPI-anchored proteins
- Post-translational protein modification
- Metabolism of proteins
Biological Process
- GPI anchor biosynthetic process
- preassembly of GPI anchor in ER membrane
Molecular Function
- N-acetylglucosaminylphosphatidylinositol deacetylase activity
Cellular Component
- endoplasmic reticulum membrane
- integral component of membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000225609
- Coding exons
- 7
- Length
- 131611
- Individuals with no LoFs
- 125694
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 54
- Defined
- 125748
- p
- 0.000215
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.0451 | 146 | 148 | 0.990 | 0.00000780 | 1644 |
| Missense (PolyPhen) | 36 | 45.676 | 0.78816 | 510 | ||
| Synonymous | -0.278 | 58 | 55.4 | 1.05 | 0.00000281 | 499 |
| Loss of Function | 0.167 | 13 | 13.7 | 0.951 | 5.90e-7 | 150 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00025 | 0.00025 | rare |
| Latino/Admixed American | 0.00049 | 0.00049 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.00027 | 0.00027 | rare |
| Finnish | 0.00034 | 0.00032 | rare |
| European (Non-Finnish) | 0.00017 | 0.00017 | rare |
| South Asian | 0.000033 | 0.000033 | rare |
| Other | 0.00016 | 0.00016 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Involved in the second step of GPI biosynthesis. De-N- acetylation of N-acetylglucosaminyl-phosphatidylinositol.;
- Disease
- DISEASE: Coloboma, congenital heart disease, ichthyosiform dermatosis, mental retardation and ear anomalies syndrome (CHIME) [MIM:280000]: An extremely rare autosomal recessive multisystem disorder clinically characterized by colobomas, congenital heart defects, migratory ichthyosiform dermatosis, mental retardation, and ear anomalies including conductive hearing loss. Other clinical features include distinctive facial features, abnormal growth, genitourinary abnormalities, seizures, and feeding difficulties. {ECO:0000269|PubMed:22444671}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.0718
Intolerance Scores
- LoFtool
- 0.558
- RVIS EVS
- -0.01
- RVIS percentile EVS
- 53.51
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.231
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |